Hook & thesis
Lockheed Martin (LMT) is a high-quality defense prime that has traded off from earlier 2026 highs but still sits on a very durable revenue base, robust free cash flow and a reliable dividend. Recent price action offers a practical entry for investors who want exposure to secular defense spending, production and sustainment cycles, and program-level earnings visibility. We're upgrading our stance to a buy and offering a concrete trade plan with entry, stop and target.
In short: the balance sheet and cash flow profile support a patient position. At $537.86 today, LMT yields roughly 2.6% and generates meaningful free cash flow ($5.662B), which can underwrite dividends, buybacks and program investments. Given modest multiple compression from cyclical headlines, we see 10-15% upside over the next several months with asymmetric downside protected by strong backlog and recurring sustainment revenue.
Business overview - why the market should care
Lockheed Martin is a global security and aerospace company operating across Aeronautics, Missiles & Fire Control (MFC), Rotary & Mission Systems (RMS), and Space. The company's cash flows are driven by long-term government contracts - the F-35 program and missile defense work are core revenue engines and provide multi-decade visibility on production and sustainment. That contractor-model means revenue is lumpy by program timing but generally predictable once contracts and budgets are secured.
Why the market should care: defense budgets in the U.S. and allied countries remain at elevated levels relative to historical norms, and Lockheed's portfolio is heavily exposed to core programs that are hard to duplicate. The company reported free cash flow of $5.662B and an enterprise value of ~$139.1B, delivering an EV/EBITDA in the mid-teens (about 15.29x), which positions LMT as a cash-rich, durable cash generator among large-cap industrials.
Supporting data and fundamentals
Key observable facts:
- Current market price: $537.86.
- Market capitalization: $124.01B and enterprise value approximately $139.12B.
- Reported free cash flow: $5.662B.
- Reported PE: ~25x (trailing), price-to-book ~16x, price-to-sales ~1.6x.
- Dividend: annualized payout implies ~2.6% yield; last declared dividend per share was $3.45 (quarterly distribution frequency, ex-dividend 06/01/2026).
- 52-week range: $410.11 - $692.00 (low 07/22/2025, high 03/02/2026).
These numbers tell a clear story: Lockheed is not a growth multiple darlings stock; it trades on program durability, free cash generation and shareholder returns. Free cash flow of $5.66B against a market cap of roughly $124B gives investors confidence that dividends and buybacks are fundable without aggressive balance-sheet moves.
Valuation framing
On trailing multiples LMT sits at ~25x earnings and EV/EBITDA ~15.3x. Those multiples reflect a premium to typical industrials but are reasonable within aerospace & defense where program visibility and margins justify higher valuations. Price-to-sales of 1.6x and price-to-book of ~16x look rich on face value, but remember a sizable portion of Lockheed's asset base is intangible program expertise and long-term contract rights not easily captured by book value.
Given the company’s cash flows, the yield and program-level revenue visibility, a mid-20s PE is defensible provided there are no major program shocks or material order cancellations. Compare that qualitatively to peers: while some defense names have lower multiples, Lockheed backs its valuation with a depth of programs and sustained margins. The valuation argument here is that the stock has priced in steady execution; near-term market volatility has created a tactical buying window rather than a structural overvaluation.
Technical context
Momentum indicators are constructive: 10-day SMA ~$508, 20-day SMA ~$519, 50-day SMA ~$520. The RSI at ~57 is neutral-to-positive and MACD shows bullish momentum. Short interest is modest with days-to-cover near 3 days on the most recent settlement date, suggesting limited structural short pressure. These technicals support a disciplined entry near current levels with a close stop to protect capital against headline risk.
Catalysts (what could drive the trade)
- New contract awards or production rate increases for the F-35 or major missile defense programs that lock in multi-year cash flows.
- Stronger-than-expected quarterly free cash flow or upward revision to program margin assumptions.
- Announcements around industrial partnerships or increased domestic production capacity (e.g., expanded supplier arrangements with large OEMs) that broaden the addressable defense manufacturing base.
- Shareholder actions such as renewed buyback authorization or incremental dividend increases funded by FCF.
Trade plan (actionable)
Entry: $537.86 - execute on a visible uptick or limit fill at current market level.
Stop loss: $490.00 - this level sits below recent support bands and the 50-day SMA, limiting downside if a program shock or broader defense derating occurs.
Target: $620.00 - target reflects upside to a modest multiple re-rating and continued organic cash flow growth. This is a realistic target over our proposed horizon.
Horizon: long term (180 trading days) - we expect this trade to play out over several quarters as program awards, quarterly FCF prints and potential buyback/dividend actions support a multiple re-rating and price appreciation.
Rationale for horizon: defense contract execution, FCF realization and corporate capital-allocation changes operate on quarterly to multi-quarter cadence. A 180-trading-day window gives time for at least two quarterly reports and potential contract headlines to surface, while limiting exposure to longer macro cycles.
Risks and counterarguments
We list the primary risks that could invalidate this trade and at least one counterargument to our bullish thesis.
- Program concentration risk: A large share of revenue is tied to legacy programs such as the F-35 and specific missile programs. Any unexpected program delays, production cuts, or major cost-reimbursement issues would pressure margins and cash flow.
- Budget & political risk: U.S. or allied defense budget shifts or sequestration-style constraints could reduce procurement or delay sustainment spend. Political cycles can lead to unpredictable timing of awards.
- Execution risk: Large defense programs are complex. Cost overruns, supplier delays or quality issues can hit margins and create renegotiations that reduce near-term earnings.
- Valuation compression: The stock trades at mid-20s earnings multiple; broad de-rating in the defense sector or a flight to safety into cash could reset multiples lower, creating capital losses even if fundamentals remain intact.
- Geopolitical shifts: A sudden diplomatic resolution to a regional conflict (or progress toward peace) could reduce near-term urgency for additional procurement, pressuring sentiment and order flows. For example, tentative diplomatic moves involving Iran have shown how geopolitics can swing risk premia.
Counterargument
One reasonable counterargument is that Lockheed’s valuation already embeds a high degree of program security and investor expectations for steady cash returns. If the market begins to prefer names with faster growth or lower leverage, LMT could underperform. Additionally, a persistent rise in interest rates would increase discount rates applied to long-duration program cash flows, weighing on the stock.
What would change our view
We would become more cautious if we saw: (1) a material downward revision to the F-35 production schedule or a high-profile contract cancellation; (2) quarterly free cash flow materially below expectations for two consecutive quarters; (3) evidence of structural margin deterioration across the primary segments; or (4) a dramatic increase in net leverage beyond management’s stated targets. Conversely, a near-term increase in buyback authorization, dividend hike, or stronger-than-expected program margins would strengthen our conviction and potentially raise the target.
Conclusion
Lockheed Martin is a classic defense-compounder with stable program revenue, strong free cash flow and shareholder-friendly returns. At today’s price of $537.86 the stock offers a balanced risk/reward: an income component (~2.6% yield), cash flow that funds capital returns, and upside if program execution meets or exceeds expectations. We're upgrading to a buy with a long-term (180 trading days) trade plan: entry $537.86, stop $490.00, target $620.00. This trade is appropriate for investors who want exposure to defense fundamentals while maintaining defined risk controls.